NCT03716583 2021-09-10
MELADERM
Herlev Hospital
Phase 2 Completed
Clinical Trials
6 trialsNCT00031967 2020-10-22
Melatonin and Radiation Therapy in Treating Patients With Brain Metastases
Radiation Therapy Oncology Group
Phase 2 Completed
NCT03205033 2017-07-02
Melatonin as a Circadian Clock Regulator, Neuromodulator and Myelo-protector in Adjuvant Breast Cancer Chemotherapy
Hospital de Clinicas de Porto Alegre
Phase 2 Completed
NCT01965522 2017-06-16
MELO-D
Juravinski Cancer Center
Phase 2 Completed
NCT02200172 2016-07-19
The Preventative Role of Exogenous Melatonin Administration in Patients With Advanced Cancer Who Are at Risk of Delirium: a Feasibility Study
Bruyère Health Research Institute.
Phase 2 Completed
NCT02430298 2016-02-24
Topical/Oral Melatonin for Preventing Concurrent Radiochemotherapy Induced Oral Mucositis/Xerostomia Cancer Patients
Khon Kaen University
Phase 2 Completed